The Washington Post: Rebates aren’t the problem. Drug companies’ prices are
September 04, 2018
The president has made it very clear he wants the same thing Americans want: for drug companies to lower their...
Filter by:
Choose a Topic
Filter by Year:Clear Filters- Highlights
- Biosimilars
- Drug Abuse Prevention
- Drug Cost Management
- Drug Coupons & Assistance Programs
- Drug Coverage Mandates
- Drug Price Negotiations & Rebates
- Formulary Design
- Fraud, Waste, & Abuse
- Generic Drug Utilization
- Home Delivery of Drugs
- Mark Merritt
- Medicaid
- Medicare Part D
- Patient Cost Sharing
- Pharmacy Networks
- Pharmacy Reimbursement & Contracting
- Specialty Pharmacies
- TRICARE
August 22, 2018
“The administration understands … PBMs are part of the solution,” Merritt said....
The Washington Examiner: Drug middlemen push back that rebates are to blame for high drug prices
August 15, 2018
Drug companies are launching new products at higher list prices, regardless of whether they get a rebate....
CNBC: Trump administration opens up more drugs covered by Medicare to price negotiations
August 08, 2018
Today’s announcement by the Administration to include greater use of PBM tools in Medicare Part B through Medicare Advantage Prescription...
Health Affairs: Spending On Prescription Drugs In The US: Where Does All The Money Go?
August 02, 2018
Total US expenditures on pharmaceutical drugs…were $480 billion…Two-thirds of this total was captured by drug manufacturers in the form of...
Managed Care Magazine: Medicare Part D Premiums To Drop Next Year
August 01, 2018
CMS said… plans have to improve quality and lower costs to attract beneficiaries. This competitive dynamic sets up clear incentives...
Kaiser Health News: Drug Trade Group Quietly Spends ‘Dark Money’ To Sway Policy And Voters
July 30, 2018
PhRMA was one of AAN’s biggest donors the previous year, giving it $6.1 million, federal regulatory findings show...
The News Virginian: Advocates fight for affordable drugs
July 27, 2018
Though drug makers continue to raise prices out of proportion to increases in value, PBMs are doing their job by...
The New York Times: Merck to Lower Prices on Some Drugs, but Not Its Blockbusters
July 20, 2018
It did not cut the prices of any blockbusters like the cancer treatment Keytruda or the diabetes drug Januvia....
Bloomberg: Many Drugmakers Ignore Trump—and Raise Prices Anyway
July 13, 2018
In the first 10 days of July, at least ten other drugmakers raised prices on at least 20 brand-name medicines...
Fierce Pharma: Trump blasts Pfizer price hikes, pledges a governmental response
July 09, 2018
President Donald Trump is trying to shame the largest U.S. drugmaker for hiking prices after he earlier said industry players were planning...
CNBC: How to know if you’re paying too much for that drug
July 06, 2018
The PCMA says in a statement it supports the patient always paying the lowest cost at the pharmacy counter, whether...